Axogen, Inc. Increase Decrease In Operating Lease Liability
Axogen, Inc. (AXGN) reported Increase Decrease In Operating Lease Liability of -$1.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-29
- Axogen, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$571.00K.
- Axogen, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$559.00K.
- Axogen, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$1.10M.
- Axogen, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$291.00K.
- Axogen, Inc. increase decrease in operating lease liability for fiscal 2025 was -$1.94M.
- Axogen, Inc. increase decrease in operating lease liability for fiscal 2024 was -$1.60M.
- Axogen, Inc. increase decrease in operating lease liability for fiscal 2023 was -$1.27M.
- Axogen, Inc. increase decrease in operating lease liability for fiscal 2022 was -$1.84M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$571.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$1.13M 10-Q · filed 2026-07-29 | -$2.23M derived: sum of 3 quarters · filed 2026-07-29 | -$2.52M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$559.00K 10-Q · filed 2026-04-28 | -$1.66M derived: sum of 2 quarters · filed 2026-04-28 | -$1.95M derived: sum of 3 quarters · filed 2026-04-28 | -$2.04M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.40M derived: sum of 2 quarters · filed 2026-02-24 | -$1.49M derived: sum of 3 quarters · filed 2026-07-29 | -$1.94M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$381.00K derived: sum of 2 quarters · filed 2026-07-29 | -$833.00K 10-Q · filed 2025-10-29 | -$1.13M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$542.00K 10-Q · filed 2026-07-29 | -$842.00K derived: sum of 3 quarters · filed 2026-07-29 | -$1.41M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$452.00K 10-Q · filed 2026-04-28 | -$752.00K derived: sum of 2 quarters · filed 2026-04-28 | -$1.32M derived: sum of 3 quarters · filed 2026-04-28 | -$1.70M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$872.00K derived: sum of 2 quarters · filed 2026-02-24 | -$1.24M derived: sum of 3 quarters · filed 2026-02-24 | -$1.60M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$943.00K derived: sum of 2 quarters · filed 2025-10-29 | -$1.30M 10-Q · filed 2025-10-29 | -$1.56M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$371.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$731.00K 10-Q · filed 2025-08-05 | -$988.00K derived: sum of 3 quarters · filed 2026-02-24 | -$1.24M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$360.00K 10-Q · filed 2025-05-08 | -$617.00K derived: sum of 2 quarters · filed 2026-02-24 | -$867.00K derived: sum of 3 quarters · filed 2026-02-24 | -$1.09M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$507.00K derived: sum of 2 quarters · filed 2026-02-24 | -$732.00K derived: sum of 3 quarters · filed 2026-02-24 | -$1.27M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$475.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.01M 10-Q · filed 2024-11-07 | -$1.53M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$762.00K 10-Q · filed 2024-08-08 | -$1.28M derived: sum of 3 quarters · filed 2025-02-26 | -$1.75M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$537.00K 10-Q · filed 2024-05-02 | -$1.06M derived: sum of 2 quarters · filed 2025-02-26 | -$1.52M derived: sum of 3 quarters · filed 2025-02-26 | -$2.06M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$521.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$985.00K derived: sum of 2 quarters · filed 2025-02-26 | -$1.52M derived: sum of 3 quarters · filed 2025-02-26 | -$1.84M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$464.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$1.00M derived: sum of 2 quarters · filed 2023-11-07 | -$1.32M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$536.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$856.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$320.00K 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$463.00K 10-K · filed 2024-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |